Veterinary Medicines

PEN-STREP 20/20, injekcinė suspensija

Authorised
  • Dihydrostreptomycin sulfate
  • Benzylpenicillin procaine
Download as PDF

Product identification

Medicine name:
PEN-STREP 20/20, injekcinė suspensija
Active substance:
  • Dihydrostreptomycin sulfate
  • Benzylpenicillin procaine
Target species:
  • Cattle
  • Pig
  • Sheep
  • Cat
  • Dog
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Dihydrostreptomycin sulfate
    250.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Benzylpenicillin procaine
    200000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        21
        day
      • Milk
        3
        day
    • Pig
      • Meat and offal
        21
        day
    • Sheep
      • Meat and offal
        21
        day
      • Milk
        3
        day
    • Cat
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • V.M.D.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/04/1649/001–002
Date of authorisation status change:

Documents

RV1649.PDF

Lithuanian (PDF)
Published on: 27/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."